Reduction of primary tumor growth and metastasis in models of triple-negative breast cancer following tilorone administration via type I interferon signaling.

Saved in:
Bibliographic Details
Title: Reduction of primary tumor growth and metastasis in models of triple-negative breast cancer following tilorone administration via type I interferon signaling.
Authors: Saunders AAE; Department of Anatomy and Physiology, Centre for Muscle Research, The University of Melbourne, Parkville, VIC, Australia., Mouchemore KA; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia., Vojtech L; Cancer Evolution & Metastasis Program, Peter MacCallum Cancer Centre, Parkville, VIC, Australia., James LS; Department of Anatomy and Physiology, Centre for Muscle Research, The University of Melbourne, Parkville, VIC, Australia., Chadwick TB; Cancer Evolution & Metastasis Program, Peter MacCallum Cancer Centre, Parkville, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia., Chi LH; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia.; Cancer Evolution & Metastasis Program, Peter MacCallum Cancer Centre, Parkville, VIC, Australia., Karagiannis C; Department of Anatomy and Physiology, Centre for Muscle Research, The University of Melbourne, Parkville, VIC, Australia., Bell C; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia., Thomson RE; Department of Anatomy and Physiology, Centre for Muscle Research, The University of Melbourne, Parkville, VIC, Australia., Parker BS; Cancer Evolution & Metastasis Program, Peter MacCallum Cancer Centre, Parkville, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia., Anderson RL; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia.; Department of Clinical Pathology, The University of Melbourne, Parkville, VIC, Australia., Gregorevic P; Department of Anatomy and Physiology, Centre for Muscle Research, The University of Melbourne, Parkville, VIC, Australia. pgre@unimelb.edu.au.; Department of Neurology, The University of Washington School of Medicine, Seattle, WA, USA. pgre@unimelb.edu.au.; The University of Melbourne, Parkville, VIC, 3010, Australia. pgre@unimelb.edu.au.
Source: Breast cancer research : BCR [Breast Cancer Res] 2026 May 07; Vol. 28 (1). Date of Electronic Publication: 2026 May 07.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42098864
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Reduction of primary tumor growth and metastasis in models of triple-negative breast cancer following tilorone administration via type I interferon signaling.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Saunders+AAE%22">Saunders AAE</searchLink>; Department of Anatomy and Physiology, Centre for Muscle Research, The University of Melbourne, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Mouchemore+KA%22">Mouchemore KA</searchLink>; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Vojtech+L%22">Vojtech L</searchLink>; Cancer Evolution & Metastasis Program, Peter MacCallum Cancer Centre, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22James+LS%22">James LS</searchLink>; Department of Anatomy and Physiology, Centre for Muscle Research, The University of Melbourne, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Chadwick+TB%22">Chadwick TB</searchLink>; Cancer Evolution & Metastasis Program, Peter MacCallum Cancer Centre, Parkville, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Chi+LH%22">Chi LH</searchLink>; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia.; Cancer Evolution & Metastasis Program, Peter MacCallum Cancer Centre, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Karagiannis+C%22">Karagiannis C</searchLink>; Department of Anatomy and Physiology, Centre for Muscle Research, The University of Melbourne, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Bell+C%22">Bell C</searchLink>; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Thomson+RE%22">Thomson RE</searchLink>; Department of Anatomy and Physiology, Centre for Muscle Research, The University of Melbourne, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Parker+BS%22">Parker BS</searchLink>; Cancer Evolution & Metastasis Program, Peter MacCallum Cancer Centre, Parkville, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Anderson+RL%22">Anderson RL</searchLink>; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia.; Department of Clinical Pathology, The University of Melbourne, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Gregorevic+P%22">Gregorevic P</searchLink>; Department of Anatomy and Physiology, Centre for Muscle Research, The University of Melbourne, Parkville, VIC, Australia. pgre@unimelb.edu.au.; Department of Neurology, The University of Washington School of Medicine, Seattle, WA, USA. pgre@unimelb.edu.au.; The University of Melbourne, Parkville, VIC, 3010, Australia. pgre@unimelb.edu.au.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100927353%22">Breast cancer research : BCR</searchLink> [Breast Cancer Res] 2026 May 07; Vol. 28 (1). <i>Date of Electronic Publication: </i>2026 May 07.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central+Ltd%22">BioMed Central Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100927353 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1465-542X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214655411%22">14655411 </searchLink><i>NLM ISO Abbreviation: </i>Breast Cancer Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42098864
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s13058-026-02296-7
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Reduction of primary tumor growth and metastasis in models of triple-negative breast cancer following tilorone administration via type I interferon signaling.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Saunders AAE
      – PersonEntity:
          Name:
            NameFull: Mouchemore KA
      – PersonEntity:
          Name:
            NameFull: Vojtech L
      – PersonEntity:
          Name:
            NameFull: James LS
      – PersonEntity:
          Name:
            NameFull: Chadwick TB
      – PersonEntity:
          Name:
            NameFull: Chi LH
      – PersonEntity:
          Name:
            NameFull: Karagiannis C
      – PersonEntity:
          Name:
            NameFull: Bell C
      – PersonEntity:
          Name:
            NameFull: Thomson RE
      – PersonEntity:
          Name:
            NameFull: Parker BS
      – PersonEntity:
          Name:
            NameFull: Anderson RL
      – PersonEntity:
          Name:
            NameFull: Gregorevic P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 07
              M: 05
              Text: 2026 May 07
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1465-542X
          Numbering:
            – Type: volume
              Value: 28
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Breast cancer research : BCR
              Type: main
ResultId 1